Series D - Celleration

Series D - Celleration

Investment Firm

Overview

Celleration is a medical device company developing and commercializing therapeutic ultrasound platforms.

Announced Date

Jul 20, 2008

Funding Type

Series D

Highlights

Location

United States, North America

Social

N/A

Investor Lead

Heron Capital

Heron Capital

Heron Capital is a late_stage_venture and private_equity firm.

CHV Capital

CHV Capital

CHV Capital is a early_stage_venture and late_stage_venture and seed firm.

Participant Investors

9

Investor Name
Participant InvestorHeron Capital
Participant InvestorAAVIN
Participant InvestorBaird Capital
Participant InvestorTriathlon Medical Venture Partners
Participant InvestorNew Science Ventures

Round Details and Background

Celleration raised $30000000 on 2008-07-20 in Series D

Celleration is a medical device company developing and commercializing therapeutic ultrasound platforms.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 31, 2002
Series B - Celleration
6-6.8M
Jul 20, 2008
Series D - Celleration
10-30.0M
Jan 04, 2013
Venture Round - Celleration
1-6.4M
Jan 12, 2011
Series E - Celleration
12-8.0M

Recent Activity

There is no recent news or activity for this profile.